 |
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
||||||||||||||||||
|
|
Understanding Private-Sector
Decision Making for Early-Stage
Technology Development
ABOUT THE AUTHORSPhilip E. Auerswald is an Assistant Professor and Director of the Center for Science and Technology Policy at the School of Public Policy, George Mason University. His research pertains to the economics of technological change, science and technology policy, and industrial organization. He is co-author with Lewis Branscomb of Taking Technical Risk: How Innovators, Executives and Investors Manage High-Tech Risks, MIT Press, 2001. He is currently a member of the research team for a multi-year National Academies study of the Small Business Innovation Research (SBIR) program. He has been a consultant to the Department of Economic Development of the Commonwealth of Massachusetts and is principal author of “Competitive Imperatives for the Commonwealth: A conceptual framework to guide the design of state economic strategy.” He holds a Ph.D. in economics from the University of Washington and a B.A. (political science) from Yale University. Lewis M. Branscomb is the Aetna Professor of Public Policy and Corporate Management emeritus and emeritus Director of the Science, Technology and Public Policy Program in the Center for Science and International Affairs at Harvard University’s Kennedy School of Government. Dr. Branscomb was graduated from Duke University in 1945, summa cum laude, and was awarded the Ph.D. degree in physics by Harvard University in 1949. A research physicist at the U.S. National Bureau of Standards (now the National Institute of Standards and Technology) from 1951 to 1969, he was Director of NBS from 1969 to 1972. He then became Vice President and Chief Scientist of the IBM Corporation, serving until 1986, when he joined the faculty at Harvard. President Johnson named him to the President’s Science Advisory Committee in 1964, and he chaired the subcommittee on Space Science and Technology during Project Apollo. President Carter appointed him to the National Science Board and he served as Chairman of the NSB during the Presidency of Ronald Reagan. Branscomb was the co-chairman of the project of the National Academies of Science and of Engineering and the Institute of Medicine, which authored the report Making the Nation Safer: Science and Technology for Countering Terrorism, published by the National Academies Press in 2002. John Nicholas Demos is the Managing Director of PharmaBio Strategy Consulting Inc., a boutique consulting firm focused on strategy issues in pharmaceutical and biotechnology related industries. His areas of expertise include industry restructuring, partnerships and alliances, pricing, business development and technology marketing. Until 2003, Mr. Demos was a vice president with Booz Allen Hamilton’s Strategy Practice based in New York. Prior to joining Booz Allen, Mr. Demos was employed as an independent consultant by a number of European companies. He holds an M.B.A. from New York University’s Leonard N. Stern School of Business where he majored in Finance and International Business. He also holds an M.S. with honors from L’École des Hautes Études Commerciales in Paris and a B.A. in Letters from Wesleyan University. Brian Min is an economic development specialist with an interest in political institutions, regional growth, and entrepreneurship. He served as manager of the Innovations in Technology and Governance project at Harvard’s Kennedy School of Government and as a consultant to the International Chamber of Commerce, the Government of Nunavut, and an Inuit nonprofit in the Canadian Arctic. He holds a BA from Cornell University and an MPP from Harvard’s Kennedy School of Government. He is currently pursuing a Ph.D. in the Department of Political Science at UCLA. Return to Table of Contents or go to next section. Date created: October 7, 2005 |
 |
ATP website comments: webmaster-atp@nist.gov / Technical ATP inquiries: InfoCoord.ATP@nist.gov. NIST is an agency of the U.S. Commerce Department |
 |